Historical Valuation
Revolution Medicines Inc (RVMD) is now in the Fair zone, suggesting that its current forward PS ratio of 5620.98 is considered Fairly compared with the five-year average of -9.27. The fair price of Revolution Medicines Inc (RVMD) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：118.64
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Revolution Medicines Inc (RVMD) has a current Price-to-Book (P/B) ratio of 9.39. Compared to its 3-year average P/B ratio of 4.00 , the current P/B ratio is approximately 134.97% higher. Relative to its 5-year average P/B ratio of 3.76, the current P/B ratio is about 149.92% higher. Revolution Medicines Inc (RVMD) has a Forward Free Cash Flow (FCF) yield of approximately -5.09%. Compared to its 3-year average FCF yield of -8.06%, the current FCF yield is approximately -36.91% lower. Relative to its 5-year average FCF yield of -8.09% , the current FCF yield is about -37.14% lower.
P/B
Median3y
4.00
Median5y
3.76
FCF Yield
Median3y
-8.06
Median5y
-8.09
Competitors Valuation Multiple
AI Analysis for RVMD
The average P/S ratio for RVMD competitors is 987.14, providing a benchmark for relative valuation. Revolution Medicines Inc Corp (RVMD.O) exhibits a P/S ratio of 5620.98, which is 469.42% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
AI Analysis for RVMD
1Y
3Y
5Y
Market capitalization of RVMD increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of RVMD in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is RVMD currently overvalued or undervalued?
Revolution Medicines Inc (RVMD) is now in the Fair zone, suggesting that its current forward PS ratio of 5620.98 is considered Fairly compared with the five-year average of -9.27. The fair price of Revolution Medicines Inc (RVMD) is between to according to relative valuation methord.
What is Revolution Medicines Inc (RVMD) fair value?
RVMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Revolution Medicines Inc (RVMD) is between to according to relative valuation methord.
How does RVMD's valuation metrics compare to the industry average?
The average P/S ratio for RVMD's competitors is 987.14, providing a benchmark for relative valuation. Revolution Medicines Inc Corp (RVMD) exhibits a P/S ratio of 5620.98, which is 469.42% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for Revolution Medicines Inc (RVMD) as of Jan 11 2026?
As of Jan 11 2026, Revolution Medicines Inc (RVMD) has a P/B ratio of 9.39. This indicates that the market values RVMD at 9.39 times its book value.
What is the current FCF Yield for Revolution Medicines Inc (RVMD) as of Jan 11 2026?
As of Jan 11 2026, Revolution Medicines Inc (RVMD) has a FCF Yield of -5.09%. This means that for every dollar of Revolution Medicines Inc’s market capitalization, the company generates -5.09 cents in free cash flow.
What is the current Forward P/E ratio for Revolution Medicines Inc (RVMD) as of Jan 11 2026?
As of Jan 11 2026, Revolution Medicines Inc (RVMD) has a Forward P/E ratio of -11.82. This means the market is willing to pay $-11.82 for every dollar of Revolution Medicines Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Revolution Medicines Inc (RVMD) as of Jan 11 2026?
As of Jan 11 2026, Revolution Medicines Inc (RVMD) has a Forward P/S ratio of 5620.98. This means the market is valuing RVMD at $5620.98 for every dollar of expected revenue over the next 12 months.